35 phenotypes from 2 alleles in 3 genetic backgrounds

Allelic Composition Genetic Background	Annotated Term	Reference
Ncoa5tm1.1(KOMP)Mbp/Ncoa5+ C57BL/6N-Ncoa5tm1.1(KOMP)Mbp/Tcp	abnormal heart morphology	J:211773
	enlarged heart	J:211773
	hydrometra	J:211773
	increased eosinophil cell number	J:211773
	increased heart weight	J:211773
	small superior vagus ganglion	J:211773
Ncoa5tm1.1(KOMP)Mbp/Ncoa5tm1.1(KOMP)Mbp C57BL/6N-Ncoa5tm1.1(KOMP)Mbp/Tcp	embryonic lethality prior to organogenesis	J:211773
	embryonic lethality prior to tooth bud stage	J:211773
	preweaning lethality, complete penetrance	J:211773
Ncoa5tm1Hxia/Ncoa5+ C.129(B6)-Ncoa5tm1Hxia	impaired glucose tolerance	J:207622
	increased fasting circulating glucose level	J:207622
	increased hepatocellular carcinoma incidence	J:207622
Ncoa5tm1Hxia/Ncoa5+ involves: 129 * C57BL/6	abnormal circulating protein level	J:207622
	abnormal epididymis physiology	J:284227
	abnormal liver morphology	J:207622
	abnormal sperm head morphology	J:284227
	abnormal sperm midpiece morphology	J:284227
	abnormal sperm mitochondrial sheath morphology	J:284227
	asthenozoospermia	J:284227
	chronic liver inflammation	J:207622
	decreased pancreatic islet number	J:207622
	decreased sperm progressive motility	J:284227
	hepatic steatosis	J:207622
	normal homeostasis/metabolism phenotype	J:207622
	impaired glucose tolerance	J:207622
	increased circulating alanine transaminase level	J:207622
	increased fasting circulating glucose level	J:207622
	increased hepatocellular carcinoma incidence	J:207622
	increased hepatocyte apoptosis	J:207622
	increased hepatocyte proliferation	J:207622
	increased liver triglyceride level	J:207622
	insulin resistance	J:207622
	liver fibrosis	J:207622
	male infertility	J:207622, J:284227
	reduced male fertility	J:284227
	normal reproductive system phenotype	J:207622
	small pancreatic islets	J:207622
	teratozoospermia	J:284227